In Silico Molecular Docking and In Vitro Antidiabetic Studies of Dihydropyrimido[4,5-a]acridin-2-amines

Table 5

% of relative movement in glucose diffusion inhibitory assay.

Time (min)	3a	3b	3c	3d	3e	3f
30	81.83±0.01	90.56±0.03	99.83±0.00	81.33±0.00	74.90±0.00	109.11±0.01
60	68.66±0.07	68.53±0.00	74.91±0.07	68.66±0.01	73.20±0.02	80.90±0.02
90	86.66±0.05	73.20±0.03	86.40±0.06	86.67±0.02	74.99±0.03	93.33±0.03
120	93.73±0.04	80.99±0.05	93.74±0.05	93.74±0.05	58.83±0.05	93.74±0.07
150	82.36±0.01	88.24±0.06	99.89±0.03	94.13±0.06	47.18±0.07	94.13±0.08
180	105.89±0.02	99.84±0.07	94.24±0.02	100±0.07	41.06±0.06	100±0.06

Values are mean ± SEM for groups of 3 observations.